Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells

por Chang, Alex Y, Wang, Miao
Publicado 2013

Brain Metastases from Breast Cancer and Response to Treatment with Eribulin: A Case Series

por Chang, Alex Y, Ying, Xu Xiao
Publicado 2015

Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B

por Lim, Joseph K, Chang, Alex Y, Zaman, Atif, Martin, Paul, Fernandez-Rodriguez, Conrado M, Korkmaz, Mete, Rossi, Simona, Ford, James M, Noonan, Tamara, Cooney, Elizabeth, Navarro, Victor, Colombato, Luis
Publicado 2020

Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma

por Hsu, Cheng-Lung, Lui, Kar-Wai, Chi, Lang-Ming, Kuo, Yung-Chia, Chao, Yin-Kai, Yeh, Chun-Nan, Lee, Li-Yu, Huang, Yenlin, Lin, Tung-Liang, Huang, Mei-Yuan, Lai, Yi-Ru, Yeh, Yuan-Ming, Fan, Hsien-Chi, Lin, An-Chi, Lu, Yen-Jung, Hsieh, Chia-Hsun, Chang, Kai-Ping, Tsang, Ngan-Ming, Wang, Hung-Ming, Chang, Alex Y., Chang, Yu-Sun, Li, Hsin-Pai
Publicado 2018